BMRN | SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc.; IMPORTANT NOV. 24 DEADLINE– BMRN

NEW YORK, Nov.04, 2020 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of BioMarin Pharmaceutical Inc.(NASDAQ: BMRN) from February 28, 2020 through August 18, 2020, inclusive (the “Class Period”).The lawsuit seeks to recover damages for BioMarin Pharmaceutical Inc.investors under the federal […]

BMRN | ROSEN, TRUSTED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important November 24 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – BMRN

NEW YORK, Oct.30, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioMarin Pharmaceutical Inc.(NASDAQ: BMRN) between February 28, 2020 and August 18, 2020, inclusive (the “Class Period”), of the important November 24, 2020…PR Newswire

BMRN | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Expected to Post Earnings of $0.25 Per Share

Wall Street brokerages predict that BioMarin Pharmaceutical Inc.(NASDAQ:BMRN) will post earnings per share (EPS) of $0.25 for the current fiscal quarter, Zacks reports.Ten analysts have provided estimates for BioMarin Pharmaceutical’s earnings, with estimates ranging from $0.17 to $0.45.BioMarin Pharmaceutical reported earnings of $0.43 per share in the same quarter last year, which […]US Banking News